Bayer - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 51,962,000 | 58,818,000 | 60,075,000 | 66,711,000 | 68,719,000 | 73,630,000 | 73,307,000 | 67,396,000 |
| Profit before tax | 1,047,000 | 1,416,000 | 1,707,000 | 4,419,000 | 1,413,000 | 818,000 | 94,000 | 7,865,000 |
| Net profit | 800,000 | 1,132,000 | 1,367,000 | 3,696,000 | 1,076,000 | 632,000 | 55,000 | 7,140,000 |
| Equity | 7,720,000 | 8,852,000 | 10,219,000 | 13,915,000 | 14,991,000 | 15,623,000 | 15,678,000 | 22,818,000 |
| Liabilities | 18,231,000 | 16,648,000 | 31,641,000 | 24,874,000 | 28,645,000 | 26,566,000 | 31,419,000 | 15,350,000 |
| Non-current assets | 622,000 | 1,094,000 | 819,000 | 784,000 | 835,000 | 1,326,000 | 1,620,000 | 1,571,000 |
| Current assets | 25,202,000 | 24,304,000 | 40,888,000 | 37,912,000 | 42,730,000 | 40,773,000 | 45,417,000 | 36,528,000 |
| Total assets | 25,824,000 | 25,398,000 | 41,707,000 | 38,696,000 | 43,565,000 | 42,099,000 | 47,037,000 | 38,099,000 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,612,171 | 3,666,487 | 3,256,332 |
| Social insurance contributions | - | - | - | - | - | 965,030 | 929,710 | 912,872 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +22.2% | +13.2% | +2.1% | +11.0% | +3.0% | +7.1% | -0.4% | -8.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.1% | 4.5% | 3.3% | 9.6% | 2.5% | 1.5% | 0.1% | 18.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.4% | 12.8% | 13.4% | 26.6% | 7.2% | 4.0% | 0.4% | 31.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.5% | 1.9% | 2.3% | 5.5% | 1.6% | 0.9% | 0.1% | 10.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.0% | 2.4% | 2.8% | 6.6% | 2.1% | 1.1% | 0.1% | 11.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.4 | 1.9 | 3.1 | 1.8 | 1.9 | 1.7 | 2.0 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 980,415 | 1,027,389 | 1,022,553 | 1,155,169 | 1,186,514 | 1,312,869 | 1,442,106 | 1,546,372 |
Sales revenue
Consolidated Bayer finance
|
EUR
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 72,467,000 | 78,515,000 | 77,089,000 | 70,089,000 |
| Profit before tax | 1,969,000 | 1,884,000 | 1,547,000 | 4,199,000 |
| Net profit | 1,565,000 | 1,637,000 | 1,426,000 | 2,212,000 |
| Equity | 19,035,000 | 20,672,000 | 22,098,000 | 24,310,000 |
| Liabilities | 29,187,000 | 27,551,000 | 32,280,000 | 16,594,000 |
| Non-current assets | 827,000 | 1,425,000 | 1,523,000 | 1,451,000 |
| Current assets | 47,341,000 | 47,065,000 | 52,878,000 | 39,502,000 |
| Total assets | 48,168,000 | 48,490,000 | 54,401,000 | 40,953,000 |
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bayer - Social security debts
The company had no debts to Sodra
Bayer - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-26 | 2025-04-28 | 11500.0 |
| 2025-02-07 | 2025-02-07 | 1556.84 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bayer, UAB (code 111818633) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €67.40M, compared with €73.31M in 2024 and €73.63M in 2023. This means revenue declined by 8.1% year on year and by 8.5% over two years. Profitability improved strongly in 2025: net profit rose to €7.14M from €55.0K in 2024 and €632.0K in 2023, lifting the profit margin to 10.6% from 0.1% a year earlier and 0.9% in 2023. The 2025 balance sheet shows total assets of €38.10M, equity of €22.82M and liabilities of €15.35M. Equity represented 59.9% of assets, while debt-to-equity stood at 0.67. Asset turnover was 1.77x, indicating solid use of assets to generate sales. Productivity was also strong, with revenue per employee at €1.57M and profit per employee at €166.0K in 2025.